Faruqi & Faruqi Obtains Final Court Approval Of $2.95 Million Settlement In Rihn v. Acadia Pharmaceuticals, Inc. et al., 15-cv-00575-BTM-DHB (S.D. Cal.)

On January 8, 2018, the Honorable Barry Ted Moskowitz, Chief Judge of the United States District Court for the Southern District of California, granted final approval of the settlement reached in Rihn v. Acadia Pharmaceuticals, Inc. et al.  Faruqi & Faruqi served as sole Lead Counsel on behalf of the Class.  The settlement provides for a cash payment of $2.95 million in exchange for plaintiffs’ release of all claims alleged in the action.  As the Court noted during the final approval hearing held on January 8, 2018, the settlement is an excellent result for the Class.